Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel QL Block vs Epidural in Colectomy
NCT03827291Phase 4Completed
- Sponsor
- Duke University
- Start
- Oct 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain, sponsored by Duke University. Primary endpoint: Cumulative Opioid Consumption Over 48 Hours. Started Oct 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03827291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827291.